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The giant elastic protein titin is a determinant factor
in how much blood fills the left ventricle during dias-
tole and thus in the etiology of heart disease. Titin has
been identified as a target of S-glutathionylation, an
end product of the nitric-oxide-signaling cascade
that increases cardiac muscle elasticity. However,
it is unknown how S-glutathionylation may regulate
the elasticity of titin and cardiac tissue. Here, we
show that mechanical unfolding of titin immunoglob-
ulin (Ig) domains exposes buried cysteine residues,
which then can be S-glutathionylated. S-glutathiony-
lation of cryptic cysteines greatly decreases the
mechanical stability of the parent Ig domain as well
as its ability to fold. Both effects favor a more exten-
sible state of titin. Furthermore, we demonstrate that
S-glutathionylation of cryptic cysteines in titin medi-
ates mechanochemical modulation of the elasticity
of human cardiomyocytes. We propose that post-
translational modification of cryptic residues is a
general mechanism to regulate tissue elasticity.
INTRODUCTION
The sarcomeric protein titin determines the passive elasticity
of heart muscle and is crucial for proper cardiac function, for
example, during diastolic relaxation of the left ventricle (Linke
and Kru¨ger, 2010). The key role of titin in the homeostasis of stri-
atedmuscle is illustrated by the recent discovery that truncations
in the titin gene are a primary cause of dilated cardiomyopathies
and centronuclear myopathy (Ceyhan-Birsoy et al., 2013; Her-
man et al., 2012; McNally, 2012; Norton et al., 2013). In addition,
a growing number of missense mutations in the elastic I-band of
titin are known to cause several forms of cardiomyopathy by
mechanisms that remain poorly understood (Anderson et al.,2013; Gerull et al., 2002; Itoh-Satoh et al., 2002; Matsumoto
et al., 2005; Taylor et al., 2011). The elasticity of muscle is adapt-
ed to its physiological needs via changes in titin. For instance,
the 363 exons contained in the titin gene can be alternatively
spliced to obtain different isoforms with tailored elastic proper-
ties (Freiburg et al., 2000). However, it remains largely unex-
plored how the elasticity of titin is regulated in short timescales
that are not compatible with protein turnover.
The elastic I-band of titin is composed of up to 100 folded
immunoglobulin (Ig) domains linked in series. Occasionally,
unstructured polypeptide regions can be found interspersed be-
tween the Ig domains (Figure 1A). Titin employs two complemen-
tary mechanisms to adapt its length to the changing mechanical
perturbations during heartbeats: entropic extension/recoil of the
unstructured regions and unfolding/refolding of Ig domains (Li
et al., 2002). Although the extent of Ig unfolding/refolding during
muscle action was amatter of debate for several years, today the
consensus in the field is that unfolding/refolding of at least some
titin domains occur in vivo and contribute to the overall elasticity
of titin (Anderson et al., 2013; Li et al., 2002;Minajeva et al., 2001;
Nedrud et al., 2011; Trombita´s et al., 1998). Unfolding of Ig do-
mains decreases titin stiffness because the residues belonging
to the unfolded domains add to the pool of unstructured regions,
which are easy to extend under force. In contrast, refolding of Ig
domains increases titin stiffness. Phosphorylation and disulfide
formation at specific residues belonging to the unstructured
regions can provide some degree of regulation of titin elasticity
(Linke and Kru¨ger, 2010). To attain larger changes in elasticity,
a regulatory mechanism would have to target the mechanical
properties of the much more abundant Ig domains. Any variation
in their mechanical stability or their refolding kinetics would lead
to changes in the overall elasticity of titin, as both effects deter-
mine the residence time of Ig domains in the unfolded state.
Titin has been identified as a likely target of increased S-gluta-
thionylation following myocardial infarction (Avner et al., 2012), a
pathology that is accompanied by augmented elasticity of the
left ventricle (Pfeffer and Braunwald, 1990). S-glutathionylation
is the end product of many redox signaling pathways, includingCell 156, 1235–1246, March 13, 2014 ª2014 Elsevier Inc. 1235
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Figure 1. Ig Domains in the I-Band of Titin
Are Rich in Cryptic Cysteines
(A) Schematic representation of a half-sarcomere.
Titin (in color) extends from the Z-disk to the M-
band of the sarcomere. The approximate location
of the I91 domain is indicated with an asterisk.
(B) Average cysteine content in the titin sequence.
(C) Structure of the titin I91 domain (also known
as I27; PDB code 1TIT), highlighting in red its two
cysteine residues.
(D) The cysteines in I91 are cryptic and can only
be S-glutathionylated after unfolding. A SUMO-
I91 construct was incubated with GSSG for 1 hr
at different temperatures. S-glutathionylation was
determined by western blotting and labeling with
anti-glutathione antibodies (a-GSH). Ponceau S
shows the total protein content.
See also Figure S1.nitric oxide signaling (Dalle-Donne et al., 2009;West et al., 2006),
which are well-recognized regulators of cardiac muscle and its
elasticity (Hare, 2004; Rastaldo et al., 2007). Previous studies
have shown that active contraction of muscle is regulated
by S-glutathionylation of ryanodine receptor 2 (Sa´nchez et al.,
2005) and sarcomeric proteins such as actin (Chen and Ogut,
2006), troponin I (Mollica et al., 2012), and myosin-binding pro-
tein C (Lovelock et al., 2012). However, the potential effects
of S-glutathionylation on the passive mechanical properties of
cardiac muscle remain unexplored.
Here, we examine the link between S-glutathionylation of
titin and changes in the elasticity of cardiac muscle. We show
that S-glutathionylation of cryptic cysteines, which are exposed
upon unfolding of titin’s Ig domains, causes increased elasticity
of titin through mechanical weakening and inhibition of folding.
These changes in titin’s mechanical properties lead to a marked
decrease in the stiffness of cardiomyocytes.
RESULTS
Titin Is a Target of S-Glutathionylation
Covalent modification of cysteine residues including S-glutathio-
nylation is a typical outcome of redox signaling (Hare, 2004;
Martı´nez-Ruiz and Lamas, 2007). S-glutathionylation has been
shown to target a very high-molecular-weight protein in murine
cardiac tissue, putatively identified as titin (Avner et al., 2012).1236 Cell 156, 1235–1246, March 13, 2014 ª2014 Elsevier Inc.However, the use of standard range
SDS-PAGE gels precluded definitive
identification of titin due to its large
size. To improve resolution in the high-
molecular-weight region, we repeated
these experiments using better-suited
SDS-vertical agarose gels (Warren et al.,
2003). After western blotting, we identi-
fied bands with the expected electro-
phoretic mobility of titin that react both
with anti-titin and with anti-glutathione
antibodies. Incubation with the reducing
agent beta-mercaptoethanol to revertS-glutathionylation selectively prevented binding of the anti-
glutathione antibody (Figure S1A available online). These results
confirm that titin is S-glutathionylated in vivo.
Cryptic Cysteines in Titin
The amino acid sequence of the Ig domains in the elastic I-band
of titin is highly abundant in cysteine residues, all of which are
potential targets for S-glutathionylation (Figure 1B; Kellermayer
and Grama, 2002). All I-band Ig domains of titin whose structure
has been determined, I1 (Protein Data Bank [PDB] code 1G1C),
I65-I70 fragment (PDB code 3B43), and I91 (also known as I27;
PDB code 1TIT; Figures 1A and 1C), contain at least two cysteine
residues that appear to be buried. Some of these cysteines are
clustered and have the potential to engage in disulfide bonds
(Mayans et al., 2001), whereas others are far from each other,
as in the case of Cys47 and Cys63 in I91 (Figure 1C). To obtain
information about the location of cysteine residues in the remain-
ing domains, we carried out homologymodeling of all Ig domains
in the I-band of the canonical human titin gene (Uniprot code:
Q8WZ42). Our analysis predicts that 89 out of 93 Ig domains in
the I-band of titin contain cryptic cysteines. These cysteines
would only become modified by redox-active molecules if the
protein domains first unfold (Figure S1B).
We tested experimentally whether the cysteines in I91 are
accessible to redox modification by incubation with oxidized
glutathione (GSSG). A cysteine residue reacts with GSSG via
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Figure 2. S-Glutathionylation of Cryptic Cysteines Inhibits Refolding of I91
(A) I91 contains two cryptic cysteines that become exposed bymechanical unfolding. At a force of 130–175 pN, the unfolding of an I91 domain can be identified as
a 25 nm step increase in end-to-end length. Exposure of the unfolded protein to GSSG leads to S-glutathionylation.
(B) A single polyprotein is unfolded at 175 pN in 100 mM GSSG and then held extended for a variable length of time (exposure time; 2 s top trace; 40 s bottom
trace). The force is then quenched to zero for 5 s to allow the protein to refold. We measure the extent of refolding by applying a probe pulse.
(C) Refolded fraction as a function of exposure time for I918 polyproteins exposed to buffer only (downward triangles; n > 35), 100mMGSSG (solid circles; n > 80),
200 mM GSH (upward triangles; n > 80) and refolded fraction in the presence of 100 mM GSSG for a mutant I918 polyprotein where all cysteine residues were
replaced by alanines (DCys, squares; n > 120). The refolded fraction was calculated as the ratio between the number of unfolding steps detected during the probe
pulse and the number of unfolding steps detected during the exposure pulse. Open symbols represent total refolding of I91 (weak + strong domains) in the
presence of 100 mM GSSG, as determined using the double-probe pulse protocol in Figure 3. Error bars represent SEM.simple thiol/disulfide exchange (Gilbert, 1990). We incubated
I91 in 5 mM GSSG at different temperatures and then detected
S-glutathionylation through western blotting and staining using
anti-glutathione antibodies. We found that I91 does not react
with GSSG at 37C, implying that the cysteines in native I91
are inaccessible to GSSG under physiological conditions (Fig-
ure 1D). However, I91 became S-glutathionylated at tempera-
tures higher than 55C, which have been shown to unfold I91
(Somkuti et al., 2013; Figure 1D). S-glutathionylation could be
reversed by incubation with 50 mM dithiothreitol (DTT), a strong
reducing agent that cleaves the mixed disulfide between
cysteine and glutathione (Figure 1D). These results confirm that
the cysteines in I91 are buried and can only be S-glutathiony-
lated when exposed to the solvent through protein unfolding.
According to our homology models, similar results are expected
for the majority of Ig domains in titin.
Cysteines found in buried positions are typically regarded
as inert and not seen as potential targets of redox signaling.
However, proteins that experience mechanical forces can beunfolded in cells (del Rio et al., 2009; Johnson et al., 2007; Li
et al., 2002; Smith et al., 2007). Hence, the mechanical unfolding
of a protein can expose cryptic cysteines that are normally inert,
making them reactive (Johnson et al., 2007; Klotzsch et al.,
2009). We hypothesized that mechanical unfolding can enable
covalent modification of titin’s cryptic cysteines, which would
disrupt the folding/unfolding dynamics and cause sustained
changes in titin elasticity. We set out to test this hypothesis using
force-clamp spectroscopy by atomic force microscopy (AFM), a
single-molecule technique that mimics themechanical perturba-
tions experienced by titin domains in the heart (Fernandez and Li,
2004; Li et al., 2002).
S-Glutathionylation of Cryptic Cysteines Inhibits Folding
of I91
We first investigated the effects of S-glutathionylation on the
refolding of I91. We mechanically unfolded and extended I91
polyproteins at a constant force of 175 pN (exposure pulse) in
the presence of 100 mM oxidized glutathione (GSSG; Figure 2).Cell 156, 1235–1246, March 13, 2014 ª2014 Elsevier Inc. 1237
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Figure 3. Graded Mechanical Modulation of I91 by S-
Glutathionylation
(A) Experimental recordings showing unfolding steps during the probe pulse
(open arrowheads). Each recording was obtained in 100 mM GSSG after a
different exposure time followed by 5 s refolding. Refolded domains with
different mechanical stability were detected using a two-level probe pulse
(110 pN in blue followed by 175 pN in red).
(B) Refolded fraction (circles and squares; left axis) and failures (triangles; right
axis) as a function of exposure time (n > 40). Squares indicate weak domains
detected during the low-force regime; circles indicate native domains
detected in the high-force regime. Data points at zero exposure time were
obtained in buffer without GSSG (open symbols; n = 24). Solid lines were
obtained from the kinetic model shown in Figure 5A. Error bars represent SEM.
See also Figure S2.Under force, 25 nm step increases in lengthmark themechanical
unfolding and extension of one I91 domain in the polyprotein
(Figure 2A). Unfolding of multiple domains produces staircase-
like changes in length, which we used to fingerprint single-mole-
cule events (Figure 2B). Mechanical unfolding exposes both
buried cysteines, which become reactive toward GSSG in the
solution, resulting in S-glutathionylation (Figure 2A). We kept
the cysteines exposed for variable amounts of time by changing
the duration of this exposure pulse (Figures 2B and 2C). We then1238 Cell 156, 1235–1246, March 13, 2014 ª2014 Elsevier Inc.ended the exposure by quenching the force to 0 pN for 5 s, allow-
ing for the collapse and folding of the I91 polyprotein (quench
pulse; Figure 2B). We quantified folding with a probe pulse
(175 pN; Figures 2B and 2C). The presence of a second staircase
of 25 nm steps marks the successful refolding of the protein.
When the exposure time was brief (2 s; Figure 2B, top trace),
folding proceeded successfully. However, when the exposure
time was increased (40 s; Figure 2B, bottom trace), allowing
for extensive S-glutathionylation of the unfolded protein, unfold-
ing steps were no longer observed during the probe pulse, indi-
cating impaired folding. The near-complete inhibition of refolding
observed after 40 s exposures toGSSGwas not seen in the pres-
ence of reduced glutathione or with buffer alone (Figure 2C). To
verify that the refolding inhibition was caused by cysteine modi-
fication, we repeated the experiment with a cysteine-free I91
mutant. Refolding of this mutant was not affected by exposure
to GSSG (DCys; Figure 2C). Taken together, these results
show that S-glutathionylation of the cryptic cysteines in I91
inhibits protein folding.
S-Glutathionylated I91 Domains Can Fold into a
Weakened State
Wenoticed that, in the presence of GSSG, unfolding events often
appeared faster in the probe pulse than in the exposure pulse.
This observation led us to believe that some of the glutathiony-
lated domains had refolded into mechanically weakened struc-
tures. In order to detect discrete populations of folded domains
with different mechanical stabilities, wemodified the probe pulse
to consist of a force ramp from 0 pN to 200 pN. In the absence of
GSSG, most of the refolded I91 domains unfolded at 150–200
pN. Strikingly, when the buffer contained GSSG, we detected
a second population of refolded I91 domains that unfolded at
much lower forces of around 100 pN (Figure S2).
To quantify the incidence of weak and native I91 domains
independently, we modified the probe pulse to include two
regimes of constant force (110 pN and 175 pN; Figure 3A). We
designed this protocol so that only weak domains would unfold
during the initial low force pulse, whereas natively folded
domains would unfold only after application of the high force.
Indeed, for short exposure pulses (2 s; Figure 3) or in the absence
of GSSG, themajority of the 25 nm steps are observed during the
high-force regime of the probe pulse, indicating mostly native
folding (circles; Figure 3B). Meanwhile, for exposure pulses
longer than 10 s, the majority of the 25 nm steps occur during
the low-force pulse (Figure 3A). Longer exposure pulses led to
overall fewer 25 nm steps in the probe pulses (Figure 3B). The
total refolding fractions detected using the single- and double-
probe pulse protocols are coincident, indicating that we
detected all refolded domains in both experiments (Figure 2C).
Given that 25 nm steps are fingerprints of folded domains,
their absence from the probe pulse can be used to detect do-
mains that failed to fold. We counted the failures (triangles; Fig-
ure 3B) as the number of unfolding steps in the exposure pulse
minus the number of unfolding steps in the probe pulse. The
failures became more frequent with increasing exposure time.
Meanwhile, the population of weakened domains peaked at an
exposure time of 10 s (Figure 3B). This transient increase in
weakened domains followed by complete inhibition of folding
A B
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Figure 4. S-Glutathionylation of Different Cysteines Produces Distinct Mechanical Phenotypes
(A) The single-cysteine mutant I91-Cys63 was mechanically unfolded and exposed to 100 mMGSSG for a variable amount of time. After a 5 s quench to allow for
folding, refolding was probed using a linear force ramp up to 240 pN.
(B) Mechanical stability of refolded I91-Cys63 after varying exposure times to 100 mM GSSG (n > 25). Solid lines indicate fits of Gaussians with fixed widths and
centroids.
(C) Refolded fraction of I91-Cys47 (triangles; n > 120) and I91-Cys63 (weak domains, squares; strong domains, circles; n > 150) at different exposure times for a
fixed quench time of 5 s in 100 mM GSSG. Data points at zero exposure time were obtained in the absence of GSSG (open symbols; n > 150). Reaction rates of
S-glutathionylation were measured from exponential fits (solid lines). Error bars represent SEM.
See also Figure S3.indicates the presence of at least three states, which is consis-
tent with the two potential S-glutathionylation sites in each I91
domain. The results can be explained by a scenario in which
S-glutathionylation of one cysteine in I91 weakens the domain
while S-glutathionylation of the second cysteine abolishes
mechanical stability altogether.
The Mechanical Effects of S-Glutathionylation Are Site
Specific
We set out to characterize the effects of S-glutathionylation at
each of the two cysteines in I91. We conducted refolding exper-
iments using single-cysteine mutants of I91 in which one of the
cysteines had been mutated to alanine. We refer to these mu-
tants as I91-Cys47 (C63A) and I91-Cys63 (C47A), respectively,
highlighting the remaining cysteine in each case. The probe
pulse consisted of a ramp from 0 to 240 pN in 6 s, which allowed
us to assess the mechanical stability of the refolded domains
(Figures 4 and S3). Exposure of I91-Cys63 to GSSG for short
periods of time led to refolded domains with native mechanical
stability, whereas longer exposure times led to weak refolded
domains that unfolded at a lower force (Figures 4A, 4B, andS3B). Weak domains were not observed for I91-Cys47, even
after exposure times in excess of 40 s (Figure S3A). We conclude
that the weak domains seen upon S-glutathionylation of I91 wild-
type (WT) are due to modification of Cys63 specifically. If we
assume similar exponential force dependence, these weak do-
mains would unfold at a rate two orders of magnitude faster
compared to native domains at any given force (Figure S3C).
The abundance of weak domains in I91-Cys63 reached a con-
stant value after 10 s and did not disappear at longer exposure
times (Figure 4C). The persistence of these weak domains
contrasts with I91 WT, where the appearance of weak domains
was transient (Figure 3B). We conclude that disappearance
of weak I91 WT domains at longer exposure times was likely
caused by a second S-glutathionylation, at Cys47.
S-glutathionylation at either Cys47 or Cys63 leads to a
decrease in total refolding (Figure 4C). To investigate if this
decrease could be explained by a decrease in folding kinetics,
we measured the folding rate of S-glutathionylated I91-Cys63
(Figure S3D). First, we unfolded the protein for 20 s in the pres-
ence of GSSG to allow for ample S-glutathionylation. We then
quenched the force for a variable amount of time and probedCell 156, 1235–1246, March 13, 2014 ª2014 Elsevier Inc. 1239
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Figure 5. Kinetic Model
(A) Scheme that includes all possible reaction pathways for S-glutathionylation and mechanical outcomes. Numbers in parentheses are the asymptotic folding
fractions.
(B) Sequence flanking the two cysteines in I91. Negatively charged residues are labeled red; positively charged residues are labeled blue.
(C) The rate of S-glutathionylation of Cys63 depends linearly on the concentration of GSSG. Error bars represent SEM.
See also Figure S4.refolding after a variety of quenching times. The folding rate of
S-glutathionylated I91-Cys63 appears indistinguishable from
the folding rate of the unmodified protein (Figure S3D). Hence,
the decrease in refolding was not caused by altered folding
kinetics. Instead, it appeared that a fraction of the glutathiony-
lated domains simply fail to fold at all. One possibility is that,
during refolding, S-glutathionylated domains have a stronger
tendency to become trapped in off-pathway misfolded states
that do not mature into folded, mechanically stable structures.
Because folding rates appeared unchanged by S-glutathiony-
lation, we took advantage of the decrease in overall folding to
measure the site-specific rates of S-glutathionylation. We found
that the first-order rate of glutathionylation at Cys63 was nearly
five times higher than the glutathionylation at Cys47 (Figures
4C and 5A). The lower reactivity of Cys47 is likely caused by
the presence of negatively charged neighboring residues (Fig-
ure 5B; Wu et al., 2011). Refolding measurements of I91-Cys63
in the presence of 10 mM GSSG confirmed that the glutathiony-
lation rate changes linearly with the concentration of GSSG, as
expected for a first-order chemical reaction (Figures 5C and S4).
Based on our results with the single-cysteine mutants, we
constructed a kinetic model that predicts the mechanical out-
comes of S-glutathionylation in I91 WT (Figure 5A). The model1240 Cell 156, 1235–1246, March 13, 2014 ª2014 Elsevier Inc.contains two classes of parameters: amplitude of folding of
each of the four states of glutathionylation and site-specific glu-
tathionylation rates k47 and k63. The only free parameter in the
model is the extent of refolding of the doubly glutathionylated
I91 WT. The value of this parameter was determined through
numerical optimization. We found that a value of 0.054 best fits
the I91 WT data (Figure 3B), confirming that folding is severely
compromised in the doubly glutathionylated I91.
The Mechanical Effects of S-Glutathionylation Are
Reversed by the Enzyme Glutaredoxin
Reversible S-glutathionylation is emerging as an important
downstream regulatory posttranslational modification in various
redox signaling pathways (Dalle-Donne et al., 2009). Although
several chemical and enzymatic pathways can lead to S-gluta-
thionylation (Gallogly and Mieyal, 2007), deglutathionylation is
mainly the result of the activity of specific enzymes, primarily glu-
taredoxin (GRX) (Lillig et al., 2008). Hence, we reasoned that GRX
could rescue refolding following S-glutathionylation of I91. To
test this hypothesis, we used an alternative pathway of S-gluta-
thionylation that is compatible with the activity of GRX. A protein-
glutathione complex can be obtained through the attack of a free
cysteine on GSSG but also through the cleavage of a protein
disulfide bond by a reduced glutathione molecule (GSH). We
took advantage of this latter route because it allows S-glutathio-
nylation in a reducing buffer, necessary to preserve GRX activity.
Because the cysteines in I91 WT are far apart and do not estab-
lish a disulfide bond, we used the mutant I9132–75. This I91
mutant readily forms a buried disulfide bond between engi-
neered cysteines at positions 32 and 75. The disulfide in
I9132–75 becomes exposed and reactive only upon mechanical
unfolding (Wiita et al., 2006; Kosuri et al., 2012; Figure 6).
When an I9132–75 protein domain is placed under a constant
stretching force of 150 pN, unfolding yields an 11 nm stepwise
increase in length, resulting in the exposure of the buried disul-
fide (Wiita et al., 2006). Cleavage of the exposed disulfide by
GSH further increases the length of the protein by 14 nm,
providing an unambiguous fingerprint for S-glutathionylation
(Figures 6A and 6C). Figure 6A shows a recording where an
I9132–75 polyprotein is first unfolded and S-glutathionylated and
then allowed to collapse and refold. Twenty-five nanometer
steps in the probe pulse indicate a refolded protein without disul-
fide. S-glutathionylated domains did not refold well, as 25 nm
steps were only rarely seen in the probe pulse (Figures 6A and
6E). Those few domains that refolded showed native mechanical
stability (Figures S5A–S5C). We repeated the glutathionylation-
refolding experiment but now in the presence of GRX in condi-
tions where the enzyme does not effectively cleave disulfide
32–75 (Figures 6B, 6D, and S5D). S-glutathionylated proteins
exposed to 45 mM GRX showed robust refolding similar to con-
trols using reduced I9132–75 in the presence of GSH, a condition
where S-glutathionylation is not possible (Figure 6E). The rescue
of protein folding by GRX shows that the mechanical effects of
I91 S-glutathionylation are reversible.
S-Glutathionylation of Cryptic Cysteines Decreases the
Stiffness of Human Cardiomyocytes
Our homology models suggest that almost all Ig domains in the
I-band of titin contain cryptic cysteines (Figure S1B). We have
shown that S-glutathionylation of cryptic cysteines softens
domain I91 by inhibiting refolding and inducing a mechanically
weak state (Figures 2, 3, 4, and S2). Hence, if I91 is a good repre-
sentative of the many cryptic-cysteine-containing domains in
titin, then S-glutathionylation would lead to large-scale changes
in the elasticity of titin by inducing extensive softening of its Ig
domains. Because titin is the major contributor to the passive
elasticity of cardiomyocytes (Linke et al., 1994), we reasoned
that the elasticity of cardiomyocytes could be regulated through
posttranslational modification of titin’s cryptic cysteines. To
test our hypothesis, we measured the passive elasticity of hu-
man cardiomyocytes in relaxing solutions containing different
redox-active molecules (Figure 7).
We subjected single cardiomyocytes to stepwise increases in
extension to different sarcomere lengths (SLs) andmeasured the
resulting passive force (Figure 7A; elasticity test). We covered
the physiological range of SLs, from 1.8 to 2.4 mm (Rodriguez
et al., 1992). Control experiments showed the expected force
profile for a stretched muscle cell, in which a sharp increase in
passive force is observed after each step in length, followed by
a slow relaxation phase (Figure 7A). It has been proposed that
the relaxation of the passive force is caused in part by mechan-ical unfolding of titin Ig domains (Minajeva et al., 2001; Tskhovre-
bova et al., 1997; Figure 7A, insets). Consistent with this notion,
the amplitude of the relaxation increases at longer SLs, indi-
cating more extensive unfolding at increasing pulling forces.
To induce S-glutathionylation of cryptic cysteines in titin, we
incubated the cardiomyocytes for 30 min with 10 mM GSSG at
long SLs (2.6–2.7 mm) that favor Ig domain unfolding (Figure 7A;
overstretch). Incubation with GSSG causes substantial softening
of the cells, as observed by the marked reduction in the passive
force measured during the subsequent elasticity test, which is
only 15% of the control force at SLs between 2.2 and 2.4 mm
(Figures 7A and 7B). The force relaxation after a step in length
was also severely diminished (Figure 7A, insets). After treatment
with GSSG, we changed the buffer to contain 10 mM GSH (SL =
2.6–2.7 mm) to revert any S-glutathionylation. Treatment with
GSH restores the passive force to 75% of the control at 2.2–
2.4 mm SL (Figures 7A and 7B). Normal relaxation kinetics were
also recovered (Figure 7A, insets). BecauseGSHbuffers are sen-
sitive to air oxidation and some S-glutathionylated residues can
resist treatment with GSH (Gilbert, 1995), we subjected the cells
to a final incubation with the strong reducing agent DTT. Incuba-
tion with 1 mMDTT makes the cardiomyocytes somewhat stiffer
than control cells (Figures 7A and 7B), a result that is compatible
with an endogenous basal level of S-glutathionylated cysteines
in cardiac titin (Avner et al., 2012).
To distinguish the contribution of cryptic cysteines from that of
cysteines that are normally exposed to the solvent, we incubated
the cardiomyocytes with 10 mM GSSG, but this time cells were
held at slack SL (1.8 mm) to minimize the extent of titin unfolding.
Under these conditions, GSSG only induces a limited decrease
in passive force during the elasticity test (Figures 7B and S6A).
During incubation at slack SL, the Ig domains of titin remain
folded and cryptic cysteines are unreactive toward GSSG.
Hence, our results show that the large decrease in cardiomyo-
cyte stiffness is mostly due to S-glutathionylation of cryptic
rather than exposed cysteines. The minor changes in elasticity
following incubation of slack cardiomyocytes with GSSG are
observed mainly at long SLs. We speculate that such variations
probably arise from Ig unfolding occurring during the elasticity
test itself, which would lead to S-glutathionylation of a small
number of cryptic cysteines.
DISCUSSION
Passive tension in cardiac muscle, which is key to the diastolic
relaxation of the left ventricle, results to a large degree from
the elasticity of the giant sarcomeric protein titin (Linke et al.,
1994). Redox signals are widespread in the cardiovascular sys-
tem and have been shown to modify the elasticity of cardiac tis-
sue, although the underlying molecular mechanisms are unclear.
We show here that S-glutathionylation of cryptic cysteines
greatly increases the compliance of the I91 domain from cardiac
titin via inhibition of folding and weakening of refolded domains.
We also demonstrate that results with I91 are generally appli-
cable to many Ig domains in the I-band of titin, because we
measure a substantial drop in the passive stiffness of human
cardiomyocytes upon S-glutathionylation of cryptic cysteines
(Figures 7A, 7B, and S6A). Hence, our findings add to theCell 156, 1235–1246, March 13, 2014 ª2014 Elsevier Inc. 1241
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Figure 6. Glutaredoxin Reverses the Mechanical Effects of S-Glutathionylation
(A) I9132–75 is S-glutathionylated through cleavage of its disulfide byGSH. Unfolding of I9132–75 increases the protein length by 11 nm, whereas S-glutathionylation
increases it further by 14 nm. Exposure-quench-probe pulse protocol probes the refolding of an I9132–75 polyprotein in the presence of 100 mMGSH. During the
exposure pulse, three unfolding events are followed by three S-glutathionylation events (solid arrowheads). The force is then quenched to zero for 5 s. No
refolding events are observed during the probe pulse.
(B) Recording showing the unfolding and S-glutathionylation of four I9132–75 domains in the presence of 100 mM GSH and 45 mM GRX. After a 5 s quench,
refolding is apparent during the probe pulse (25 nm steps; open arrowheads).
(C) Diagram of unfolding and S-glutathionylation of I9132–75. Numbers indicate the associated step sizes detected in force-clamp.
(D) GRX-mediated deglutathionylation.
(E) Refolded fraction after a 5 s quench in 100mMGSHwith or without 45 mMGRX. A baseline for refolding wasmeasured using prereduced I9132–75 polyprotein in
the presence of 100 mM GSH (n > 90). Error bars represent SEM.
See also Figure S5.growing pool of evidence supporting that Ig unfolding controls
the elasticity of titin at physiological SLs.
Cryptic cysteines remain inert as long as the parent domains
remain folded. Mechanical force accelerates protein unfolding1242 Cell 156, 1235–1246, March 13, 2014 ª2014 Elsevier Inc.(Schlierf et al., 2004), which makes cryptic cysteines available
for modification. In our experiments, we used high forces
in order to trigger rapid unfolding and S-glutathionylation,
so that we could observe mechanical effects in a timescale
AB C
Figure 7. Modulation of Cardiomyocyte Elasticity by S-Glutathionylation of Cryptic Cysteines in Titin
(A) Single human cardiomyocytes were pulled to different sarcomere lengths, and the resulting passive force wasmeasured (elasticity test). Elasticity was probed
initially and after subsequent incubations with 10 mM GSSG, 10 mM GSH, and 1 mM DTT; all incubations were done at long sarcomere lengths (2.6–2.7 mm;
overstretch) to induce unfolding of titin Ig domains. Incubation times are indicated. Top trace shows the stretch protocol; bottom trace shows the resulting
average passive tension generated by cardiomyocytes. Results are the average of at least eight cells. Insets show magnification of the relaxation phase after
stretching the cardiomyocytes to SL = 2.4 mm.
(B) Mean peak force measured at various SLs. GSSG slack is an experiment where incubation with GSSG was done in relaxed cardiomyocytes (SL = 1.8 mm).
Forces are normalized to the force measured at 2.4 mm SL in control conditions. Error bars represent SD. Inset: scheme of the experimental setup.
(C) Model of regulation of muscle elasticity through S-glutathionylation of cryptic cysteines in titin.
See also Figure S6.compatible with single-molecule instrumentation. Whereas the
forces we used are higher than forces experienced under
normal physiological conditions, even low forces lead to pre-
dictable, nonzero rates of mechanical unfolding. To illustrate
the interplay between mechanical force and time in the context
of modification of cryptic cysteines of titin, we conducted
Monte Carlo simulations (Figures S6B–S6H). We simulated
the response of a simplified model of titin to a continuous
cyclical force protocol between 0.1 and 30 pN, which roughly
mimics a human heartbeat (Figure S6B). Individual stretch-relax
cycles gave rise to force-extension curves (Figure S6C). As
expected from the low forces experienced by titin in the simu-
lations, protein unfolding was only rarely observed. Conse-
quently, the stiffness of titin showed minor variations between
subsequent cycles but did not consistently change over a time-
scale of hours (Figures S6C and S6F, black trace). After 6 hr of
continuous cycles, we introduced 100 mM GSSG. No notice-able change was observed in the first few cycles after this
addition. However, over a time course of hours, the proportion
of S-glutathionylated domains increased significantly, leading
to persistent unfolded states and decreased titin stiffness (Fig-
ures S6D and S6F, red trace). Titin stiffness could be restored
to its original value by introduction of GSH (Figure S6E).
Simulations further show that the steady-state stiffness of titin
depends on the redox potential of the GSH/GSSG buffer
(Figure S6G).
OurMonte Carlo simulations suggest that changes in elasticity
due to S-glutathionylation of titin probably develop on a time-
scale of minutes to hours (Figure S6F). However, other cellular
pathways leading to S-glutathionylation are more effective than
simple thiol/disulfide exchange and therefore would lead to
faster regulation of titin elasticity (Gallogly and Mieyal, 2007).
Also, many domains in titin are less mechanically stable than
I91 and may thus be more sensitive to S-glutathionylationCell 156, 1235–1246, March 13, 2014 ª2014 Elsevier Inc. 1243
(Li et al., 2002). We speculate that, in pathological events where
the redox homeostasis changes abruptly, for instance during
ischemic episodes (Giordano, 2005), excessive oxidative modi-
fication of cryptic cysteines can lead to an aberrant increase in
elasticity. However, because modifications of cryptic cysteines
do not occur instantly, there may be a window of opportunity
for therapeutic intervention to limit damage to the elasticity of
heart muscle. In this context, it has been shown that increased
titin stiffness leads to diastolic dysfunction (Chung et al., 2013).
Our results raise the possibility that cryptic cysteines can be
pharmacologically targeted in failing hearts to revert the stiffness
of titin back to a physiological range.
We propose that redox-mediated modulation of titin elastic-
ity provides adaptation to the changing chemical status of
myocytes in both skeletal and cardiac muscle (Figure 7C).
Being able to adjust its own elastic output to the biochemical
environment in a use-dependent manner is a fascinating prop-
erty of titin and constitutes a form of mechanical memory. We
are just beginning to understand how such mechanochemical
feedback is accomplished. The fact that stretching heart
cells activates signaling through reactive oxygen species
adds an additional layer of complexity to the interplay between
mechanical forces and the redox environment (Prosser et al.,
2011). In the case of titin, it will be interesting to examine
the mechanical effects of alternative redox posttranslational
modifications that compete with S-glutathionylation, such as
nitrosylation, sulfenylation, etc.
The mechanomodulatory effects reported here are not neces-
sarily restricted to titin. Cryptic cysteines that become exposed
under mechanical loads have recently been identified in elastic
proteins of the cytoskeleton and the extracellular matrix, such
as spectrin (Johnson et al., 2007; Krieger et al., 2011), ankyrin
(Krieger et al., 2011), vimentin (Johnson et al., 2007), fibronectin
(Klotzsch et al., 2009), and nuclear lamin-A (Swift et al., 2013).
Although commonplace in elastomeric proteins, no regulatory
role for cryptic cysteines has been suggested so far. We propose
that the modulation of mechanical properties by posttransla-
tional modifications of cryptic residues represents a general
mechanism to regulate protein elasticity.EXPERIMENTAL PROCEDURES
Protein Expression and Purification
The cDNAs coding for 8 mers of I91, the Cys-to-Ala I91 mutants, and I9132–75
were cloned in the plasmid pQE80 (QIAGEN), and the corresponding polypro-
teins were purified as described before (Alegre-Cebollada et al., 2011).
Measurement of I91 Cysteine Accessibility to GSSG
A fusion protein SUMO-I91 (0.6 mg/ml) was incubated with 5 mM GSSG at
different temperatures for 1 hr. Then, Laemmli sample buffer including 2 mM
maleimide was added. Samples were incubated at 90C for 15 min before
SDS-PAGE. The inclusion of 2 mM maleimide ensures that all cysteines that
are exposed during denaturation of the sample for SDS-PAGE are blocked
and do not react with GSSG. S-alkylation by maleimide is much faster than
S-glutathionylation. Control experiments showed that no S-glutathionylation
is detected when SUMO-I91 is boiled in the presence of 5 mM GSSG and
2 mM maleimide. To show reversibility by DTT, we incubated the samples
with 50 mM DTT at 90C for 15 min before loading in the SDS-gel. After
electrophoresis and western blotting, S-glutathionylation was detected using
anti-GSH monoclonal antibodies (Virogen).1244 Cell 156, 1235–1246, March 13, 2014 ª2014 Elsevier Inc.Single-Molecule Atomic Force Microscopy
We used custom-built force-clamp AFM setups that have been described in
previous publications (Fernandez and Li, 2004) or a commercial force-clamp
AFM (Luigs and Neumann; Popa et al., 2013). All AFM experiments were con-
ducted in degassed solution consisting of 10 mM HEPES (pH 7.2), 150 mM
NaCl, and 1 mM EDTA. We coated freshly evaporated gold coverslips with
the polyprotein of interest by adding a small aliquot (less than 10 ml) of polypro-
tein solution (0.2–1mg/ml). Polyproteins were adsorbed for several minutes on
the gold surface. Then, buffer was added to the AFM fluid cell and the exper-
iment was started after in situ calibration of the cantilever using the equiparti-
tion theorem (Popa et al., 2013). Single molecules were picked up by pushing
the cantilever against the gold surface at a contact force of 0.5–2 nN for 1 s.
Then, the piezoelectric actuator was retracted by applying a pulling force. If
a tether had been formed, the force rapidly stabilized at the set point. The
tether was maintained until the force protocol ended or spontaneous detach-
ment occurred. Refolded fractions were calculated as the ratio between the
number of unfolding events in the probe pulse and in the exposure pulse.
Once set up, AFM experiments run automatically in the same buffer for hours
or even days.We did not observe any changes in the results with time since the
start of the experiment, in agreement with I91 cysteines being buried in the fold
of the protein (see also Figure 1D).
Data Analysis
Data were analyzed using custom-written software in IGOR Pro (Wavemet-
rics). We included in the analysis traces that showed a fingerprint of two or
more unfolding events in the exposure pulse. Only traces that reached the
same length at the end of exposure and probe pulses were selected. This cri-
terion ensured that the same molecule was attached in both pulses. Traces
showing steps that could not be identified either as unfolding or reduction
events were excluded from the analysis. For the I91-Cys63 refolding data,
weak and strong refolded domains were quantified from double Gaussian
fits to the histograms shown in Figure 4B. In these fits, the widths and centroids
were held constant across the data sets, leaving only two free parameters (i.e.,
the amplitudes of the Gaussians). The numbers of weak and strong domains in
each condition were then determined given the total number of folded domains
and the relative amplitude of the two Gaussians. In refolding experiments, the
number of independent observations N for a particular condition was counted
as the total number of protein domains (as observed in the exposure pulse).
SEM was estimated using the bootstrap method (Efron, 1982). In the force
histograms, N is the number of observations. S-glutathionylation rates were
determined from refolding experiments in 100 mM GSSG using the single-
cysteine mutants (Figure 4). k47 = 0.33 M
1s1 was measured from an expo-
nential fit to the time course of folding inhibition upon exposure to GSSG
(gray line in Figure 4C). k63 = 1.6 M
1s1 was measured as the average of
the rate of disappearance of the strong domains (red line in Figure 4C)
and the rate of appearance of the weak domains (blue line in Figure 4C). To
examine the GSSG concentration dependency of the reaction, k63 was also
measured in 10 mM GSSG (Figure 5C). To obtain the refolding fraction of
the doubly glutathionylated I91, we fit the data in Figure 3B to the kinetic model
in Figure 5A (see Extended Experimental Procedures).
Cardiomyocyte Elasticity Tests
Skinned cardiomyocytes were prepared from deep-frozen human donor heart
tissue (Hamdani et al., 2013). Samples were defrozen in relaxing solution (in
mmol/l: free Mg, 1; KCl, 100; EGTA, 2; Mg-ATP, 4; imidazole, 10 [pH 7.0]), me-
chanically disrupted and incubated for 5min in relaxing solution supplemented
with 0.5% Triton X-100. The cell suspension was washed five times in relaxing
solution. Single cardiomyocytes were selected under an inverted microscope
(Zeiss Axiovert 135; 403 objective; numerical aperture 0.75) and attached with
silicone adhesive to micromanipulator-positioned glass microneedles con-
nected to a force transducer and a piezoelectric motor as part of a ‘‘permea-
bilized myocyte test system’’ (1600A; with force transducer 403A; Aurora
Scientific). SL was monitored using a video camera and analysis software pro-
vided by the manufacturer. To measure elasticity, single cardiomyocytes were
exposed to stepwise increases in extension from SL = 1.8 mm (slack) to 2.4 mm,
in increments of 0.1 mm every 10 s. We included in the final analysis only those
cells that were capable of active contractile force generation within 30%
variation compared to the maximum Ca2+-activated force at the start of the
experiment. According to this criterion, 10% of measured cells were dis-
carded. Hence, treatments with GSSG, GSH, and DTT did not induce irrevers-
ible damage to the cells.
Experiments with Human or Animal Subjects
The investigation with human samples conformed to the principles outlined in
the Declaration of Helsinki and was approved by the Ethics Committee at Ruhr
University Bochum (entry 3447–09). Experiments with mouse samples were
carried out under the review and approval of the University of Illinois at Chicago
Animal Care Committee ACC: 11-229.
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